Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care - Top-Institutions - MDSpire

Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care

  • By

  • Yuxiu Dai

  • Hengyang Liu

  • Dingwen Xu

  • June 26, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    MARS cohort
    MARS cohort

    N/A, N/A

    Key Differentiators

    • Critical Care

  • #2

    Aix Marseille Université
    Aix Marseille Université

    Marseille, Provence-Alpes-Côte d'Azur

    Key Differentiators

    • Critical Care

  • #3

    Deutsche Sepsis-Gesellschaft
    Deutsche Sepsis-Gesellschaft

    N/A, N/A

    Key Differentiators

    • Critical Care

  • #4

    Surviving Sepsis Campaign
    Surviving Sepsis Campaign

    N/A, N/A

    Key Differentiators

    • Critical Care

  • #5

    Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)
    Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

    N/A, N/A

    Key Differentiators

    • Critical Care

Original Source(s)

Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care

  • by Yuxiu Dai, Hengyang Liu, Dingwen Xu

  • June 26, 2026

Related Content

Teaching AI to Read Liquid Biopsies

Researchers explore whether large language models can support cfRNA biomarker discovery

  • June 26, 2026

  • 2 min
Antimicrobial use and resistance awareness among conventional poultry producers in Hossaina town, Central Ethiopia

Infectious disease outcomes in end-stage renal disease: the influence of dialysis type on patient vulnerability in Hail region